Vantia
Closed portfolio with an early-phase archive tilt
According to ClinicalTrials.gov-derived indexes, Vantia sits in the upper quartile of US sponsors by registered trial count (#2,085 of 15,742 sponsors by registered trial count).
Vantia: 6 sponsored US clinical trials, none currently recruiting.
Vantia sponsors 6 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 6 completed. 0 of these trials are in Phase 3-4 (later-stage) and 6 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Primary Dysmenorrhea, with 1 trials.
Upper-quartile sponsor footprint
Vantia sits in the upper quartile of the sponsor corpus (#2,085 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
6 total, page 1 of 1
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
NCT02637960
Dose Range Finding Study of Fedovapagon in Men With Nocturia
NCT01656239
VA106483 Dose Response in Females
NCT01171391
Efficacy Study of VA106483 in Males With Nocturia.
NCT01038843
VA111913 Dysmenorrhoea Efficacy and Safety Proof of Concept
NCT00963053
VA106483 Dose Response Study in Elderly Males
NCT00922740
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 4 |
Therapeutic Areas
How the Vantia early-phase archive is shaped
6 indexed studies, none listed as recruiting (0% open); 6 completed (100%).
Phase mix: 0 late (III/IV) vs 6 early (I/II) (early-phase heavy).
Top condition: Primary Dysmenorrhea (1 trial), 0 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Vantia: archived-pipeline peers nationwide
Peers matched on 6 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Vantia sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 6 archived trials
- 23andMe · 6 trials · 0% recruiting
- Aardvark Therapeutics · 6 trials · 0% recruiting
- Abbisko Therapeutics Co · 6 trials · 67% recruiting
- AbGenomics B.V Taiwan Branch · 6 trials · 0% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
- 3 Waves Wellness · 0% recruiting · 2 trials
Related
What to do with this Vantia page
6 registered trials is a research-attention snapshot, not an endorsement of Vantia or any single study.
- None of Vantia's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Primary Dysmenorrhea is the condition Vantia studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Primary Dysmenorrhea trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Vantia pipeline card: 6 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.